The Truong lab investigates the possibilities of our genomes by writing in synthetic DNA hundreds of kilobases at a time.
This capability will enable us to build sophisticated cellular programs — arming our cells with functionalities to perhaps fight cancer, autoimmune disease, neurodegeneration, or age-related diseases.
We engineer human pluripotent stem cells (iPSCs), the
start of all other cells. We then coax them
into immune cells as living therapies or
tissue cells for regenerative medicine.
We aspire to codify the grammar
and language of cellular
Make better, safer and more accessible cell therapies and regenerative medicines by manipulating the genome.
Inclusion, Respect, Understanding, Integrity, Impact, Innovation, Creativity, Wonder, Work-Life Balance
Synthetic Genomes and Cell Therapies
The Truong lab has open positions for a Postdoctoral Fellow and a PhD student in specific research areas.
The Truong lab officially opened on September 1st, 2021 at New York University Tandon School of Engineering. The lab will be located in the east medical corridor by the School of Medicine in Manhattan.
The Truong Lab has been awarded an NIH Director's New Innovator award (DP2) from the National Institute of Allergy and Infectious Diseases (NIAID) for 5 years.